Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach

Cancer

Volumn 103, Issue 7, 2005, Pages 1439-1446

  Kim, Min A ^a   Lee, Hye Seung ^a   Yang, Han Kwang ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Cardia; Immunohistochemistry; Stomach neoplasms; Surgical pathology; Survival analysis; Tissue array method

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HERMES ANTIGEN; MUCIN 1; MUCIN 5AC; PROTEIN P16; SMAD4 PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARDIA CARCINOMA; CLINICAL FEATURE; DISEASE CLASSIFICATION; DUODENUM ULCER; FEMALE; GENE OVEREXPRESSION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

CARCINOMA; CARDIA; FEMALE; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 15744378109     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20966     Document Type: Article

References (30)

1. Howson CP, Hiyama T, Wynder EL. The decline of gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1-27.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594-606.
3. Hundahl SA, Menck HR, Mansour EG, Winchester DP. The National Cancer Data Base report on gastric carcinoma. Cancer. 1997;80:2333-2341.
4. Breaux JR, Bringaze W, Chappuis C, Cohn I Jr. Adenocarcinoma of the stomach: a review of 35 years and 1710 cases. World J Surg. 1990;14:580-586.
5. Akoh JA, Macintyre IM. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg. 1992;79:293-299.
6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
7. Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev. 1992; 1:265-269.
8. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993; 104:510-513.
9. Locke GR 3rd, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology. 1995;109:1750-1756.
10. Siewert JR, Holscher AH, Becker K, Gossner W. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg. 1987;58:25-32.
11. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer. 1987;60:1094-1109.
12. Gray JR, Goldman AJ, MacDonald WC. Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer. 1992;69:2227-2231.
13. Pinheiro PS, van der Heijden LH, Coebergh JW. Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Lauren type and subsite. Int J Cancer. 1999;84:28-32.
14. Kajiyama Y, Tsurumaru M, Udagawa H, et al. Prognostic factors in adenocarcinoma of the gastric cardia: pathologic stage analysis and multivariate regression analysis. J Clin Oncol. 1997;15:2015-2021.
15. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg. 1995;180:577-582.
16. Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, Shimoda T. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology. 2001;61:1-9.
17. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002.
18. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. 2001;92: 1427-1434.
19. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
20. Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003;200:39-46.
21. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169-1179.
22. Ramon JM, Serra L, Cerdo C, Oromi J. Dietary factors and gastric cancer risk. A case-control study in Spain. Cancer. 1993;71:1731-1735.
23. Flucke U, Steinborn E, Dries V, et al. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophagogastric junction and proximal stomach. Histopathology. 2003;43:127-134.
24. Gulmann C, Hegarty H, Grace A, Leader M, Patchett S, Kay E. Differences in proximal (cardia) versus distal (antral) gastric carcinogenesis via the retinoblastoma pathway. World J Gastroenterol. 2004;10:17-21.
25. Driessen A, Van Raemdonck D, De Leyn P, et al. Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer. 2003;39:2487-2494.
26. Driessen A, Nafteux P, Lerut T, et al. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol. 2004;17:49-55.
27. Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer. 1994;73:2239-2249.
28. Chapel F, Fabiani B, Davi F, et al. Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology. 2000;36:252-261.
29. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res. 2004;10:1698-1705.
30. Ichikura T, Ogawa T, Kawabata T, Chochi K, Sugasawa H, Mochizuki H. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma? World J Surg. 2003;27:334-338.